Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The MacBlue Binary Transgene (csf1r-gal4VP16/UAS-ECFP) Provides a Novel Marker for Visualisation of Subsets of Monocytes, Macrophages and Dendritic Cells and Responsiveness to CSF1 Administration.
Exploratory validation of a multidimensional power wheelchair outcomes toolkit.
Myeloid cells as target of fingolimod action in multiple sclerosis.
Temperature dependence of water diffusion pools in brain white matter.
Characterization of anti-natalizumab antibodies in multiple sclerosis patients.
Early treatment with high-dose interferon beta-1areverses cognitive and cortical plasticity deficits in multiple sclerosis.
Oral BG-12 in multiple sclerosis.
The over time development of chronic illness self-management patterns: a longitudinal qualitative study.
Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity.
SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica.
Environmental factors acting during development to influence MS risk: insights from animal studies.
Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: Implications for remyelination at lesions sites.
Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis.
Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regeneration.
Characterizations of reflex and nonreflex changes in spastic multiple sclerosis.
MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No.
Intractable vomiting and hiccups as the presenting symptom of neuromyelitis optica.
The association of -330 interleukin-2 gene polymorphism with its plasma concentration in Iranian multiple sclerosis patients.
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.
Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
Can the irradiated brain be salvaged by oligodendrocyte precursor transplantation?
Multiple sclerosis: Neuroimaging provides insights into cognitive dysfunction in MS.
No Overlap among Serum GAD65, NMDAR and AQP4 Antibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
Pages
« first
‹ previous
…
377
378
379
380
381
382
383
384
385
…
next ›
last »